Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers

Alblihy, Adel; Shoqafi, Ahmed; Toss, Michael S.; Algethami, Mashael; Harris, Anna E.; Jeyapalan, Jennie N.; Abdel-Fatah, Tarek; Servante, Juliette; Chan, Stephen Y.T.; Green, Andrew; Mongan, Nigel P.; Rakha, Emad A.; Madhusudan, Srinivasan

Abstract

The MRE11–RAD50–NBS1 (MRN) complex is critical for genomic stability. Although germline mutations in MRN may increase breast cancer susceptibility, such mutations are extremely rare. Here, we have conducted a comprehensive clinicopathological study of MRN in sporadic breast cancers. We have protein expression profiled for MRN and a panel of DNA repair factors involved in double-strand break repair (BRCA1, BRCA2, ATM, CHK2, ATR, Chk1, pChk1, RAD51, γH2AX, RPA1, RPA2, DNA-PKcs), RECQ DNA helicases (BLM, WRN, RECQ1, RECQL4, RECQ5), nucleotide excision repair (ERCC1) and base excision repair (SMUG1, APE1, FEN1, PARP1, XRCC1, Pol β) in 1650 clinical breast cancers. The prognostic significance of MRE11, RAD50 and NBS1 transcripts and their microRNA regulators (hsa-miR-494 and hsa-miR-99b) were evaluated in large clinical datasets. Expression of MRN components was analysed in The Cancer Genome Atlas breast cancer cohort. We show that low nuclear MRN is linked to aggressive histopathological phenotypes such as high tumour grade, high mitotic index, oestrogen receptor- and high-risk Nottingham Prognostic Index. In univariate analysis, low nuclear MRE11 and low nuclear RAD50 were associated with poor survival. In multivariate analysis, low nuclear RAD50 remained independently linked with adverse clinical outcomes. Low RAD50 transcripts were also linked with reduced survival. In contrast, overexpression of hsa-miR-494 and hsa-miR-99b microRNAs was associated with poor survival. We observed large-scale genome-wide alterations in MRN-deficient tumours contributing to aggressive behaviour. We conclude that MRN status may be a useful tool to stratify tumours for precision medicine strategies.

Citation

Alblihy, A., Shoqafi, A., Toss, M. S., Algethami, M., Harris, A. E., Jeyapalan, J. N., Abdel-Fatah, T., Servante, J., Chan, S. Y., Green, A., Mongan, N. P., Rakha, E. A., & Madhusudan, S. (2021). Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers. npj Breast Cancer, 7(1), 1-10. https://doi.org/10.1038/s41523-021-00350-5

• Journal Article Type: Article
• Acceptance Date: Oct 22, 2021
• Online Publication Date: Nov 15, 2021
• Publication Date: Nov 15, 2021
• Deposit Date: Nov 12, 2021
• Publicly Available Date: Nov 16, 2021
• Journal: npj Breast Cancer
• Electronic ISSN: 2374-4677
• Publisher: Nature Publishing Group
• Peer Reviewed: Peer Reviewed
• Volume: 7
• Issue: 1
• Article Number: 143
• Pages: 1-10
• DOI: https://doi.org/10.1038/s41523-021-00350-5
• Keywords: Pharmacology (medical); Radiology Nuclear Medicine and imaging; Oncology
• Public URL: https://nottingham-repository.worktribe.com/output/6680883
• Publisher URL: https://www.nature.com/articles/s41523-021-00350-5